WebApr 10, 2014 · Background: The role of fibrinolytic therapy in patients with intermediate-risk pulmonary embolism is controversial. Methods: In a randomized, double-blind trial, we … WebA post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial Clin Res Cardiol. 2024 Jul ... (PEITHO) trial, we focused on 219 survivors of acute intermediate-risk PE with clinical and echocardiographic follow-up 6 months after randomisation as well as over the long term (median, 3 years after acute PE). The primary outcome was a ...
PEITHO - Wiki Journal Club
WebThe Pulmonary Embolism Thrombolysis (PEITHO) trial evaluated a single-dose tenecteplase with heparin therapy for the treatment of “intermediate risk” acute pulmonary embolism. … WebHI-PEITHO is a multi-center, prospective, randomized, controlled trial in the U.S. and Europe that will compare the outcomes of ultrasound-facilitated, catheter-directed, thrombolysis … the doors 1970
Pulmonary Embolism International THrOmbolysis Study-3 …
WebJul 14, 2024 · Join us to learn more about HI-PEITHO, a transatlantic, prospective, randomized, controlled trial. HI-PEITHO will compare the outcomes of ultrasound-facilitated, catheter-directed, thrombolysis (with the EKOSTM Endovascular System) plus anticoagulation vs. anticoagulation alone for the treatment of acute, intermediate-high … WebJun 10, 2024 · PEITHO was an appropriately powered randomized trial that informed our practice regarding use of systemic thrombolysis in intermediate-risk PE. 2 It is time to ask … WebApr 27, 2024 · The PEITHO (Pulmonary Embolism Thrombolysis) trial was a randomized (1:1) comparison of th rombolysis with tenecteplase versus placebo in normotensive patients with acute PE, right ventricular (RV) dysfunction on imaging, and a positive cardiac troponin test result. Both treatment arms received standard anticoagulation. the doors 1991 part 1